All Updates

All Updates

icon
Filter
Funding
Bluejay Diagnostics raises USD 8.75 million in underwritten public funding to settle outstanding debt obligations and advance clinical R&D
Precision Medicine
Jun 27, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Precision Medicine

Precision Medicine

Jun 27, 2024

Bluejay Diagnostics raises USD 8.75 million in underwritten public funding to settle outstanding debt obligations and advance clinical R&D

Funding

  • Bluejay Diagnostics recently priced a firm commitment underwritten public offering. Aegis Capital Corp led the planning. The funds expected to be generated are ~USD 8.75 million (gross).

  • The funds will be used to repay an outstanding debt of USD 2.3 million and other various pursuits, including FDA approvals, clinical studies, other R&D activities, and general working capital requirements.

  • Bluejay Diagnostics is a medical diagnostics company specializing in rapid, near-patient testing systems to improve patient outcomes in critical care settings. The company's flagship Symphony System product facilitates whole-blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force. Its primary product candidate, the IL-6 test for sepsis triage, supports medical decision-making. Bluejay also offers the ALLEREYE diagnostic test for allergic conjunctivitis and is developing cardiac biomarkers such as hsTNT and NT pro-BNP​.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.